Position in RLAY
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$72,053,535
+$57,805,108 QoQ
Shares Held
3,851,071
+168.9% QoQ
Ownership
1.76%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#15
of 256 holders
Holding Since
Sep 2020
24 quarters on record
Voting authority
Sole 98%
Shared 0%
None 2%
Common Shares in RLAY Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026MORGAN STANLEY holds $16,717,848,806 across 523 Biotechnology names. RLAY ranks #49 (0.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RPRX |
Royalty Pharma plc
|
42,931,597 | $2,407,174,637 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
3,242,139 | $1,610,467,694 | |
| 3 | ROIV |
Roivant Sciences Ltd.
|
42,592,905 | $1,507,362,901 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,397,712 | $871,529,332 | |
| 5 | MRNA |
Moderna, Inc.
|
9,538,094 | $667,952,718 | |
| 6 | ARGX |
Argenx SE
|
643,123 | $596,670,219 | |
| 7 | TECH |
BIO-TECHNE Corp
|
6,374,717 | $450,373,747 | |
| 8 | INCY |
Incyte Corp
|
2,948,364 | $334,226,536 |
All Filings in RLAY
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $72,053,535 | 3,851,071 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $14,248,427 | 1,432,003 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $17,076,203 | 2,018,464 | Shares | Defined | 2026-05-27 | |
| 2025-09-30 | $9,208,578 | 1,764,096 | Shares | Defined | 2026-05-27 | |
| 2025-06-30 | $4,921,314 | 1,422,346 | Shares | Defined | 2025-08-15 | |
| 2025-03-31 | $4,174,145 | 1,593,186 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $5,359,170 | 1,300,770 | Shares | Defined | 2025-05-15 | |
| 2024-09-30 | $6,811,743 | 962,111 | Shares | Defined | 2025-05-14 | |
| 2024-06-30 | $8,099,648 | 1,242,278 | Shares | Defined | 2025-05-14 | |
| 2024-03-31 | $9,603,270 | 1,157,021 | Shares | Defined | 2024-10-17 | |
| 2023-12-31 | $8,023,028 | 728,704 | Shares | Defined | 2024-08-16 | |
| 2023-09-30 | $5,529,915 | 657,541 | Shares | Defined | 2023-11-15 | |
| 2023-06-30 | $9,764,983 | 777,467 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $9,258,343 | 562,134 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $35,397,996 | 2,369,344 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $7,658,164 | 342,341 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $10,487,574 | 626,124 | Shares | Defined | 2022-10-27 | |
| 2022-03-31 | $12,914,193 | 431,480 | Shares | Defined | 2022-10-27 | |
| 2021-12-31 | $16,076,468 | 523,493 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $14,087,318 | 446,791 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $20,843,307 | 569,645 | Shares | Defined | 2021-08-23 | |
| 2021-03-31 | $16,960,317 | 490,608 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $5,351,223 | 128,759 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $4,443,201 | 104,325 | Shares | Defined | 2020-11-13 | |
| No filing history on record for this holder in this stock. | ||||||